Innovation Pharmaceuticals Inc (IPIX)

[frrol]

BP are always on the lookout for new cancer therapies. Always. And there are billions in capital available to fund them. And p53 modulation is an unproven but enticing approach. And Kevetrin is a legitimate clinical research candidate. And it has extremely short bioavailability, effectively requiring a pill for testing. And we are working on that. And IPIX is extremely capital deficient. And we have very limited data on K at effective doses.

So our situation is that no BP has thrown money at us yet for K, and we're trying to get the K pill ready for early clinical testing with little money, which is why it's taking years. And the hope is that management is truthful that there are BP watching and ready to deal when they get comfortable. I strongly suspect that is likely and that management is credible on this. I hope that BP get comfortable once the pill is ready for a Phase 1B, not after. This is what I am looking for when it comes to K. Given the time that's passed, I will not be surprised if we get a "K pill is ready" announcement before the end of the year.